NASDAQ:DRMA | Free Cash Flow | Dermata Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.48M
2025-12-31-$1.33M
2025-03-31-$1.93M
2024-12-31-$2.91M
2024-03-31-$2.7M
2023-12-31-$1.15M
2023-03-31-$1.65M
2022-12-31-$1.83M
2022-03-31-$2.61M
2021-12-31-$1.8M
2021-03-31-$776,220.00
2020-12-31-$7.52M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$7.76M
2024-12-31-$11.16M
2023-12-31-$6.41M
2022-12-31-$8.83M
2021-12-31-$5.69M
2020-12-31-$4.03M